Phylogica has successfully delivered the Cre enzyme used in biological research into lung, liver and kidney cells during in vivo experiments, proving the ability of its original cell penetrating peptide to deliver intracellular drug cargos. The company is now preparing to test its current lead CPP that is about twice as effective as the original CPP in the same animal model.
Related Data & Insights
-
-
Rank Company Revenue 87th PYC Therapeutics $15.8m 90th GreenHy2 $15.0m 91st K2fly $14.8m 93rd Advanced Braking Technology $14.7m 94th DTI Group $13.3m 202 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Related Articles
14 Mar 2024
PYC taps investors for $75m
02 Jan 2024
Nedlands company joins Google in AI project
11 May 2023
Perth biotech company raises $30m
07 Nov 2022
Healthtech banks on rising numbers
15 Jul 2022
Exal Group buys $44m Freo warehouse
13 May 2022
Hockings hopes for blindness drug
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX